Crofelemer: In HIV Associated Diarrhea and Secretory Diarrhea - A Patent Perspective.

CONCLUSION: Crofelemer is a first-in-class agent that possesses a unique mechanism of action through dual inhibition of both the intestinal chloride channels in secretory diarrhea.
PMID: 25851117 [PubMed - in process]

Source: Recent Patents on Anti-Infective Drug Discovery - June 4, 2015 Category: Infectious Diseases Tags: Recent Pat Antiinfect Drug Discov Source Type: research